← Open Payments lookup

LACY GUEDON: Open Payments

NPI 1922484757 · WINNSBORO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$668 in 31 payments from 10 companies in 2025. Trend: 2023 $465 · 2024 $682 · 2025 $668

Food & beverage: $668
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.6$133
Janssen Pharmaceuticals, Inc6$108
ABBVIE INC.4$82
Vanda Pharmaceuticals Inc.3$81
Alkermes, Inc.3$58
Axsome Therapeutics, Inc.3$57
Corium, LLC2$54
E.R. Squibb & Sons, L.L.C.2$51
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
Takeda Pharmaceuticals U.S.A., Inc.1$19

Products named: REXULTI, INVEGA SUSTENNA, VRAYLAR, FANAPT, ARISTADA, Auvelity, Azstarys, COBENFY.

Industry payments across LA — which companies pay providers there.